BOARD OF DIRECTORS
Bill is an Australian businessman and philanthropist with expertise in real estate, banking, funds and asset management.
Bill spent 23 years as a senior executive and Executive Director with Macquarie Group, the pre-eminent Australian investment bank, where he managed The Global Banking and Real Estate businesses. Bill founded, grew and led Macquarie Real Estate Group to a point where it managed over $30 billion worth of investments around the world.
Bill Moss was responsible for creating and building businesses in the areas of real estate investment, property funds management, finance and banking, tourism and leisure, and mortgage banking. At the time of his resignation in December 2006, the business had grown to over 1,400 staff, located in USA, Europe, UK, Japan, China, Hong Kong, Singapore, New Zealand and Australia, which led to one of Macquarie Group’s most profitable businesses. Bill has been a director of eight listed property trusts and one listed infrastructure trust.Bill was the Co-Chair of the Territory 2030 Steering Committee and part of Australia’s 2020 summit.
Having donated his time over 30 year period to being a Founder, Director and Patron of some fourteen charities and community groups, in 2015, Bill was awarded one of Australia’s highest honours, Office of the Order of Australia (AO), for services to the banking, charity, and finance sectors.
Bill is currently Chairman of Moss Capital, Chairman of Boston Group of Companies and non-executive director of Elanor Investments Pty Ltd. Bill is Chairman and Founder of The FSHD Global Research Foundation.
Nigel Virgo is a Sydney based Partner of KPMG Australia. Nigel leads the Foundation’s Finance committee and has been a member and Director of the Foundation since 2007.
Nigel has been a specialist assurance practitioner in the Real Estate, Construction and Funds Management industries for the last 14 years. He is a Registered Company Auditor, a member of the institute of Chartered Accountants in Australia and holds a certificate of public Practice and Bachelor of Commerce degree.
He has extensive experience in the property industry and has been involved in many high profile companies across the Australian Market. His focus is on providing high quality assurance and other services to his clients and maintain long term trusted relationships.
Natalie Cooney is an entrepreneurial philanthropist at heart. Having grown up with FSHD in her family, she is burning to finding treatments and an ultimate cure for FSHD. Her infectious passion, professionalism, expertise in the field and personal story drives her and her team to fight to improve the quality of life for people living with this muscle wasting disease.
Volunteering for the Foundation since its establishment, she recently took reign as Managing Director, and in a short period of time has been quick to achieve, innovate and motivate, setting a new tone, pace for research, brand and voice to the award winning charity – changing the culture of giving, bringing transparency and accountability to the sector, and dramatically increasing fundraising and community engagement, expanding world class medical research by 35% within her first year: driven to improve diagnostics, therapeutics and clinical trials for FSHD.
Barry Robinson joined Wyndham Vacation Resorts Asia Pacific in September 2003 as CEO and Managing Director. In 2009, he launched Wyndham Hotel Group in the South Pacific. Barry has been the driving force behind many significant new property acquisitions, enhanced resort developments and has brought a renewed customer focus to the business. Under his leadership, both Wyndham Vacation Resorts Asia Pacific and Wyndham Hotel Group in the South Pacific have expanded their portfolios throughout Australia, New Zealand, the South Pacific and South East Asia.
Appointed President and Managing Director of Wyndham Hotel Group South East Asia and Pacific Rim on January 1, 2015, Barry continues to lead the expansion of both Wyndham Vacation Resorts Asia Pacific and Wyndham Hotel Group across the region. Barry oversees a property portfolio of more than 81 hotels and resorts under seven different brands.
“I feel very privileged to be on the Board of FSHD and proud of the achievements to date with regards to the research undertaken. This is a devastating condition which we must continue to work hard on to find a cure.”
Andrew Rigney is a partner of B P Woodward & Associates, Chartered Accountants in Sydney and is a Fellow of the Institute of Chartered Accountants in Australia. Andrew holds a Bachelor of Commerce degree from Macquarie University and a Diploma of Law from the Legal Profession Admissions Board. Andrew holds a number of directorships in private companies and charitable foundations. Andrew is also a sworn Justice of the Peace in New South Wales
Dr. Alan Watts has had a biomedical career spanning 25 years, with experience in the fields of science, business and technology. Alan has an Honours degree in Science, for which he majored in Chemistry and Genetics, and he completed his Doctorate in Molecular Immunology at the University of Sydney.
Alan has research experience in the general field of molecular immunology and cytokines, and practical experience with biologic manufacturing. He has designed bio-copies of anti-TNF biologic medicines. Alan has published a number of papers and is named on several patents.
Alan currently holds the position of Associate Medical Director in the ANZ division of US pharmaceutical company AbbVie. In addition to being Board member and Chairing the Science Committee of the muscular dystrophy-focussed FSHD Global Research Foundation, Alan gives his time for a second not-for profit medical philanthropic organisation in his role as Trustee of the Wenkart Foundation.
Malcolm is a former Macquarie Banker and co-founder of the SMILE Foundation (Supporting Medical Innovation for Life Enhancement); helping children with rare medical conditions.
Malcolm has been a director of both private and public companies and has experience in strategy and implementation for a variety of venture capital projects ranging from funds management to biotech businesses; from early stage through to full commercialisation.
The Beville Group has recently focused on owning and managing shopping centres such as the Marrickville Metro, sold to AMP and the repositioning of the Darling Harbour Harbourside complex subsequently sold to Mirvac for some $250m. Malcolm holds a BComm (UNSW) and a Masters in Counselling and Psychotherapy.
Glenn has extensive industry knowledge with over 25 years’ experience in the Australian and international capital markets.
Glenn was most recently co-founder and Chief Executive Officer of Moss Capital. Prior to Moss Capital, Glenn co-founded Grange Securities and led the team in his role as Managing Director and CEO. Grange Securities was a pre-eminent Australian owned investment bank with businesses in fixed income, equities, corporate finance and funds management. Grange Securities grew to be Australia’s major independent fixed income house.
Glenn previously held senior positions at Fay Richwhite and Challenge Bank.
Beverly has been involved with the FSHD Global since its inception. Beverly brings with her over 40 years of experience in the not-for-profit sector.
Beverly worked with Bill Moss at Macquarie as the Corporate Social Responsibility Manager for Banking and Real Estate.Currently Beverly is the Executive Officer of the Aboriginal Education Council (NSW), a charity established to support Aboriginal students in NSW and their access to all educational opportunities.
Dr. Pradnya Dugal MBBS(Hons)FRANZCR is a radiologist practising in Sydney.
Graduating with First Class Honours from the University of Sydney Faculty of Medicine, she undertook her specialist training at Royal Prince Alfred Hospital, graduating as a dual gold medallist from the Royal Australian and New Zealand College of Radiology. Dr. Dugal has undertaken subspecialty radiology fellowships in the USA at New York University and Thomas Jefferson University. She is a founding partner of the Synergy Radiology network of medical imaging practices throughout Sydney, which also provide radiology services to various hospitals including St Vincent’s Private Hospital, Blacktown Hospital and Hospital for Specialist Services.
Bechara has over 20 years of experience providing legal and business advisory services across a diverse set of industries. He is currently the Group Managing Director of Madison Marcus Law Firm. Prior to this Bechara acted as the Managing Director of Consolidated Lawyers for more than 15 years. Bechara’s leadership has been recognised by some of the legal professions most prestigious awards. In 2017, Bechara has been named a finalist for Law Firm Leader of the Year and in 2016 he was named a finalist for Managing Partner of the Year.
Bechara acts as a corporate advisor to many private, public and foreign companies as well as associations and companies limited by guarantee. He provides advice on international joint ventures, off take agreements, managed funds and capital raising, master franchises and private acquisitions.
A seasoned deal-maker, Bechara regularly acts for large and reputable developers and builders in relation to all aspects of land dealing, having worked on many major developments in New South Wales in 2015 – 2016.
Bechara provides consulting to a number of private companies as a Non-Executive Director. He is currently the business and legal advisor to the board of Argus Global and Piety THP. He is also a Director of financial advisory services including Madison Marcus Advisory and Transcend Capital. He is the Legal Counsel and former Committee Member and Treasurer of the Australian Indian Business Council.
Bechara has acted as a business mentor to the Australian Business Women’s Network. He was previously on the legal academic board of representatives for the International Institute of Business Management. Bechara is also a member for the Australian Institute of Company Directors, the Urban Development Institute of Australian and the Australian Chamber of Commerce and Industry.
Bechara is committed to supporting local community and charitable organisations and throughout his career has made a positive contribution to organisations including the FSHD, Westmead Medical Research Foundation, Westmead Children’s Hospital, the Sydney’s Children’s Hospital and the Cancer Council. He has also participated in the Nepean Inter-Youth Programme, mentoring youths and providing them with support and free meals.
Dr. Baker graduated from the University of Melbourne in 1999. In 2007, he completed specialist training in Endocrinology before undertaking a PhD in type 2 diabetes and dietary interventions through the University of Melbourne, completing in 2012. He is a Consultant Endocrinologist and General Physician at Austin Health and lectures for the University of Melbourne and Royal Australasian College of Physicians. He has been involved with FSHD Global since 2010 and was part of the working group for the FSHD Clinical Practice Recommendations published in 2016.
Pete has 20 years’ commercial, operations management & advisory experience in global strategic consultancy roles across Europe, the US, Asia & Australia.
He is the founder, Chairman and CEO of Agincourt Advisory, a private market advisory firm specializing in diversified alternative assets & pursing opportunistic interests in Private Debt, Real Estate, Private Equity & Venture asset classes, focusing on a broad range of industries & sectors including Healthcare, Technology, Renewable Energy, Clean / Green Tech, Financial Services & Fintech, Agriculture & Ag Tech, Commercial Realty, Education, Aged Care & Tourism.
Agincourt provides robust portfolio diversification strategies by identifying & responding to special opportunities across divergent asset classes & sectors with low correlation to the volatility of public markets.
Pete is also a director of Agincourt Bio Consulting pty ltd which he founded after working in the global Life Science strategic consultancy arenas in Europe, the US, Asia and Australia.
Agincourt Bio Consulting is a boutique advisory firm, specializing in providing uniquely tailored approaches to partner identification, commercialization strategies and targeted exposure to Investor networks for the Healthcare, Life Science and Medical Device industries.
Agincourt Bio Consulting works with biotech, tier 1 and 2 pharma, medical device and diagnostic clients supporting corporate strategic planning, licensing, strategic business development, alliance management, IP commercialization, capital raising, cross border engagement & joint venture’s taking advantage of the IP appetite from Asian markets.
Prior to founding Agincourt Pete headed up the Healthcare business within Datamonitor (part of the Informa group), a leading market analyst firm providing strategic research, bespoke high level, complex consultancy and commercial, strategic and business operations advisory services.
Pete joined Datamonitor in London supporting clients across Europe & the US. In 2007 returned to Australia to manage the Asia Pacific healthcare operation.
Past roles include Australian Sales Director for Truven Health Analytics, a US based healthcare big data and global health economics outcomes provider, acquired by IBM Watson health in 2016 for $2.6 billion USD.
Presently working for St John of God Foundation.
Results focused business management influencer, widely acknowledged as a ‘big picture’ visionary with advanced initiative, drive and commitment. A good capacity to juggle multiple projects and budgets simultaneously to raise funds. Motivation to succeed, overcome challenges and improve standards coupled with exceptional ability to build strategic alliances which consistently deliver long-lasting sustainable partnerships. Inherent capacity to analyse and transform data into realistic strategies that deliver results and enhance the level of benefit created. The main goal always, is to make a difference to health outcomes for Australian.
David Mackay is a great supporter of the Foundation and has been actively involved with FSHD. David is currently Director of Fortune Brands Home & Security Inc. (since Oct 2011)n and also sits on the Keurig Green Mountain board (Since 2013). He is a member of the Kalamazoo Institute of Arts (Trustee) (since 2009).
David has extensive Australian and international retail and consumer goods experience. He had a long career with Kellogg in Australia, retiring as Chief Executive Officer and President of Kellogg Company in January 2011 after holding a number of key positions within the company in the United Kingdom and the United States of America. David took on the role of Chairman of McGrath Real Estate in July 2015.